Approvals/TGA/ZAIDA 3/30 drospirenone/ethinyloestradiol 3 mg/30 microgram tablet blister composite pack

Approved

STANDARD

ZAIDA 3/30 drospirenone/ethinyloestradiol 3 mg/30 microgram tablet blister composite pack

Alphapharm Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 6945f8529e13b445
Product Name: ZAIDA 3/30 drospirenone/ethinyloestradiol 3 mg/30 microgram tablet blister composite pack
Artg Id: 219082
Artg Name: ZAIDA 3/30 drospirenone/ethinyloestradiol 3 mg/30 microgram tablet blister composite pack
Sponsor: Alphapharm Pty Ltd
Company Detail Path: /organization/alphapharm-pty-ltd
Artg Date: 2022-05-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

6945f8529e13b445

Type

Standard